Clinical trial

Lidocaine, Dexmedetomidine, Esmolol and Magnesium Effect on Optic Nerve Sheath Diameter After Laryngoscopy

NCT06254534

Study summary

ClinicalTrials.gov

Lidocaine, Dexmedetomidine, Esmolol and Magnesium Effect on Optic Nerve Sheath Diameter After Laryngoscopy

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DIAGNOSTIC_TEST · Unmapped registry intervention optic nerve ultrasonography Find medicine records · Find other trials using this name

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2024-02-14

PhaseNA

Conditions

Intracranial Hypertensionverified · MONDO: intracranial hypertension

Endotracheal Intubationunresolved

Optic Nerve Sheath Diameterunresolved

General Anesthesiaunresolved

Interventions

optic nerve ultrasonographyDIAGNOSTIC_TEST

Sponsors & collaborators

Haseki Training and Research Hospitallead sponsor

Mapped research locations

IstanbulTurkey (Türkiye)1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06254534 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.